Antimicrobial Hospital Textiles Market Report 2026

Antimicrobial Hospital Textiles Market Overview

• Antimicrobial Hospital Textiles market size has reached to $11.13 billion in 2025 • Expected to grow to $17.4 billion in 2030 at a compound annual growth rate (CAGR) of 9.3% • Growth Driver: Surge In Awareness Of Hospital-Acquired Infections Boosts Antimicrobial Hospital Textiles Market • Market Trend: Copper-Infused Antimicrobial Scrubs Drive Innovation In Healthcare • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Antimicrobial Hospital Textiles Market?

Antimicrobial hospital textiles refer to fabrics that have been treated with chemicals or manufactured with chemicals to limit the growth of bacterial germs on the fabric. It is utilized for hospital beds, curtains, and linens. The main types of antimicrobial hospital textiles are cotton, polyester, polyamide, and other types (polyethylene, polypropylene, acrylic, and cellulose acetate). Cotton refers to the staple fiber, made up of many fibers of various lengths. The usability is disposable and reusable, which involves FDA class I, class II, and class III. The hospital departments include the general ward, surgical room, infectious disease ward, ICU, and other hospital departments, that involve various uses such as medical uniforms and apparel, upholstery, surgical textiles, incontinence care garments, wound treatment, and other applications.

What Is The Antimicrobial Hospital Textiles Market Growth Forecast?

The antimicrobial hospital textiles market size is expected to see strong growth in the next few years. It will grow to $17.4 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for sustainable medical textiles, rising focus on reusable hospital products, expansion of infection prevention protocols, growing adoption of advanced antimicrobial materials, increasing regulatory emphasis on hospital hygiene. Major trends in the forecast period include increasing adoption of antimicrobial textile treatments, rising demand for infection-control hospital fabrics, growing use of reusable antimicrobial textiles, expansion of icu and surgical textile applications, enhanced focus on patient safety and hygiene.

Global Antimicrobial Hospital Textiles Market Segmentation

1) By Type: Cotton, Polyester, Polyamide, Other Types 2) By Usability: Disposable, Reusable 3) By FDA Class: Class I, Class II 4) By Hospital Department: General Ward, Surgical Room, Infectious Disease Ward, ICU, Other Hospital Departments 5) By Application: Medical Uniform And Apparels, Upholstery, Surgical textiles, Incontinence Care Garments, Other Applications Subsegments: 1) By Cotton: Conventional Cotton, Organic Cotton, Blended Cotton 2) By Polyester: Regular Polyester, Recycled Polyester, Blended Polyester 3) By Polyamide: Nylon 6, Nylon 66, Blended Polyamide 4) By Other Types: Polyethylene, Polypropylene, Acrylic, Cellulose Acetate

What Is The Driver Of The Antimicrobial Hospital Textiles Market?

The increase in awareness of hospital-acquired infections is expected to propel the growth of the antimicrobial hospital textiles market going forward. Hospital-acquired infections are infections obtained during medical care at a healthcare facility from a healthcare practitioner, such as a doctor or nurse. Antimicrobial hospital textiles help to reduce healthcare-acquired infections by affecting the digestive tract, urinary tract, skin, lungs, and bloodstream with substances that are used to stop the growth and spread of bacteria. For instance, in June 2025, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023–24, hospital-acquired complications were reported in 150,000 hospitalizations out of a possible 12.6 million hospitalizations. Therefore, rising awareness of hospital-acquired infections is driving the antimicrobial hospital textiles industry.

Key Players In The Global Antimicrobial Hospital Textiles Market

Major companies operating in the antimicrobial hospital textiles market are Sinterama S.p.A., Trevira GmbH, PurThread Technologies Inc., LifeThreads LLC, Thai Acrylic Fiber Co. Ltd., Herculite Products Inc., Toyobo Co. Ltd., Baltex Group Limited, Microban International Ltd., Sciessent LLC, BASF SE, Lonza Group AG, BioCote Limited, Resil Chemicals Pvt. Ltd., Archroma Management LLC, HeiQ Materials AG, Milliken & Company, Vestagen Technical Textiles Inc., Copper Clothing Ltd., Applied Silver Inc., 3M Company, Ahlstrom‑Munksjö Oyj, American Dawn Inc., Medline Industries Inc., Angelica Corporation, Hospital Specialty Company Inc., BSN Medical Inc., Cramer Products Inc.

Global Antimicrobial Hospital Textiles Market Trends and Insights

Major companies operating in the antimicrobial hospital textiles market are focusing on developing innovative solutions, such as copper‑infused, eco‑healthtech medical scrubs, to meet the rising demand for infection control and hospital-acquired‑infection (HAI) prevention in healthcare settings. These scrubs embed copper into natural fabrics like cotton, bamboo, and linen, giving them durable antimicrobial properties unlike traditional scrubs that rely solely on frequent laundering or surface disinfection, these fabrics inherently reduce microbial load. For instance, in June 2023, Swiss Precision Active, a Switzerland-based eco-healthtech apparel company, unveiled its CopperActive antimicrobial scrubs at the FIME Miami Fair. The CopperActive line is made from a patented blend of copper and natural organic fibers, is lab‑tested and verified by SGS and other labs, and is designed to kill or inhibit dangerous bacteria over time. These scrubs are lightweight, moisture-wicking, odour-resistant, and maintain their antimicrobial efficacy even after repeated washing, making them especially suitable in high-risk hospital environments to reduce pathogen transmission.

What Are Latest Mergers And Acquisitions In The Antimicrobial Hospital Textiles Market?

In October 2024, 1888 Mills Inc., a US-based textile manufacturing company, partnered with Fuze Technologies Inc. With this partnership, 1888 Mills aims to integrate Fuze Technologies’ antimicrobial innovations into its textile products to enhance hygiene, safety, and durability for commercial and hospitality applications. Fuze Technologies Inc. is a US-based technology company that specializes in developing antimicrobial surface treatments and technologies that prevent the growth of bacteria and other pathogens on fabrics and surfaces.

Regional Outlook

Asia-Pacific was the largest region in the antimicrobial hospital textiles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the antimicrobial hospital textiles market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Antimicrobial Hospital Textiles Market?

The antimicrobial hospital textiles market consists of sales of medical curtains, bed sheets and pillow coverings, and mattresses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.